2014.1-8 FDA approved drug

2014.1-8 FDA approved drug

No.	Drug Name	Active Ingredient	Date	What It’s Used For
23.	Orbactiv	oritavancin	8/6/2014	To treat adults with skin  infections   Press Release
22.	Jardiance	empagliflozin	8/1/2104	To improve gylcemic control  in adults with type 2 diabetes   Press Release
21.	Striverdi  Respimat	olodaterol	7/31/2014	To treat chronic obstructive  pulmonary disease   Press Release
20. / y* i6 x% Y2 w3 C5 y	Zydelig	idelalisib	7/23/2014	To treat patients with trhee  types of blood cancers   Press Release
19.	Kerydin    ! E" X6 q' i: Z# `) k- W* }) \	tavaborole	7/7/2014	For the topical treatment of  onychomycosis of the toenails   (No Press Release)
18.	Beleodaq	belinostat	7/3/2014	To treat patients with  peripheral T-cell lymphoma (PTCL) ! e/ Z, C1 J  t  Press Release
17.	Sivextro (tablet)Sivextro  (injection)	tedizolid phosphate	6/20/2014	To treat adults with skin  infections $ ]) S/ G5 [' C9 `( \9 b9 Q% B  Press Release
16.	Jublia	efinaconazole	6/6/2014	Treat mild to moderate  onychomycosis (fungal infection)    No Press Release
15.	Dalvance $ Q3 T- T# A3 E/ D2 G. Q) Q   : h( I# }- [- Q) R2 |2 K6 X	dalbavancin	5/23/2014	To treat adults with skin  infections ! l( _  s& b; L8 _2 m$ W2 G  _- U$ L  Press Release
14.	Entyvio	vedolizumab	5/20/2014	To treat adult patients with  moderate to severe ulcerative colitis and adult patients with moderate to  severe Crohn‘s disease   Press Release
13.	Zontivity    / j* V" Y* \4 E1 t$ B) b) n	vorapaxar	5/8/2014	To reduce the risk of heart  attacks and stroke in high-risk patients   Press Release
12.	Zykadia	ceritinib	4/29/2014	To treat patients with a  certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC) ( E7 R' S/ x! T9 l3 q9 T6 y  Press Release
11.	Sylvant	siltuximab	4/23/2014	To treat patients with multicentric  Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the  lymph nodes) 0 y$ r" K2 ~- Q5 z0 }+ Q  Press Release
10.	Cyramza	ramucirumab	4/21/2014	To treat patients with  advanced stomach cancer or gastroesophageal junction adenocarcinoma   Press Release
9.	Tanzeum	albiglutide	4/15/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes - X3 |& W/ U( n) p& N5 `3 J7 i. A  Press Release
8.	Otezla	apremilast	3/21/2014	To treat adults with active  psoriatic arthritis (PsA) / w1 j, Q# g, Q# W7 p  Press Release
7.	Impavido	miltefosine	3/19/2014	To treat a tropical disease  called leishmaniasis 9 i6 Z. e" U1 B* o2 V  Press Release
6.	Neuraceq	florbetaben F 18 injection	3/19/2014	For Positron  EmissionTomography (PET) imaging of the brain
5.	Myalept	metreleptin for injection	2/24/2014	To treat the complications  of leptin deficiency   Press Release
4.	Northera	droxidopa	2/18/2014	To treat neurogenic  orthostatic hypotension (NOH)   Press Release
3.	Vimizim	elosulfase alfa	2/14/2014	Treatment for Mucopolysaccharidosis Type IVA  (Morquio A syndrome)   Press Release
2.	Hetlioz	tasimelteon	1/31/2014	To treat non-24- hour sleep-wake disorder (“non-24”)  in totally blind individuals. Non-24 is a chronic circadian rhythm (body  clock) disorder in the blind that causes problems with the timing of sleep.Press Release
1.	Farxiga	dapaglifozin	1/8/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release

# x! Y* E0 h0 `& G- Q4 N; W

) P, P$ n8 t9 ~

感谢楼主分享，楼主好强大